Bausch Health Companies 10K Form

Sell

47

BHC.TO
Bausch Health Companies

Last Price:

11.09

Seasonality Move:

11.53%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-06	10Q	BHC.TO/Bausch Health Companies Quarterly
2020-05-07	10Q	BHC.TO/Bausch Health Companies Quarterly
2020-02-19	10K	BHC.TO/Bausch Health Companies Annual
2019-11-04	10Q	BHC.TO/Bausch Health Companies Quarterly
2019-08-06	10Q	BHC.TO/Bausch Health Companies Quarterly
2019-05-06	10Q	BHC.TO/Bausch Health Companies Quarterly

Receive BHC.TO News And Ratings

See the #1 stock for the next 7 days that we like better than BHC.TO

BHC.TO Financial Statistics

Sales & Book Value

Annual Sales:	$11.82B
Cash Flow:	$453.98M
Price / Cash Flow:	2.96
Annual Sales:	$-4.31
Price / Book:	0

Profitability

EPS (TTM):	-0.65170
Net Income (TTM):	$-241.65M
Gross Margin:	$8.37B
Return on Equity:	0%
Return on Assets:	-0.67%

Bausch Health Companies Earnings Forecast

Key Bausch Health Companies Financial Ratios

The Gross Profit Margin over the past 31 years for BHC.TO is 70.78%.
The Selling, General & Administrative Expenses for BHC.TO have been equal to 33.31% of Gross Profit Margin.
The Research & Development expenses have been 6.90% of Revenue.
The Interest Expense is -224.32% of Operating Income.
The Net Earning history of BHC.TO is -6.76% of Total Revenues.
Per Share Earnings over the last 31 years have been positive in 15 years.

Bausch Health Companies Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	TSX
Industry:	Pharmaceuticals
Sector:	Health Care
Current Symbol:	BHC.TO
Website:	bauschhealth.com

Debt

Debt-to-Equity Ratio:	-18.32
Current Ratio:	1.19
Quick Ratio:	0.62

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	1.85

BHC.TO Technical Analysis vs Fundamental Analysis

Sell

47

Bausch Health Companies (BHC.TO) is a Sell

Is Bausch Health Companies a Buy or a Sell?

Bausch Health Companies stock is rated a Sell
The current Bausch Health Companies [BHC.TO] share price is $11.09. The Score for BHC.TO is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.